China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Model Construction and Clinical Validation of Plasma cfDNA Methylation Signatures for Adjuvant Diagnosis of Renal Cell Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133030
Registration Time: 2026/09/21
Type: Diagnostic test
Primary Sponsor: Chinese PLA General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343750
Published by HT Digital Content Services with permission from Health Daily Digest....